Clinical Trials Browser

Phase 3 × Breast Neoplasms × apatinib × Clear all

NCT07371910 2026-01-28

Fluorizoparib Plus Apatinib Versus Chemotherapy in HRD-positive, HER2-negative Advanced Breast Cancer

Phase 3 Active not recruiting

Breast Neoplasms